GERON CORP (GERN) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income-$28.9M

EPS$-0.13

Market Cap$819.9M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

John Scarlett

CEO & Executive Director

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Employees: 82
Headquarters: FOSTER CITY, CA, United States
Website: www.geron.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-12.78%

ROA?

-5.06%

D/E Ratio?

1.53

📊

Profitability Ratios

Current Ratio?

4.66

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Jul 19, 2026 (in 54 days)

Annual Report (10-K) — Estimated

Jul 19, 2026

Predicted10-K

Mar 2, 2026

10-KQ4 202510d after period end

Data Freshness

Financial Data

1mo ago

Latest filing: 2026-03-02

SEC Metadata

2mo ago

Latest filing: 2026-03-02

Loading company sections...

The morning brief, before the bell.

GERON CORP

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades